Research Article

In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide

Table 1

In vitro activity of nitazoxanide (NTZ) and its active metabolite tizoxanide (TIZ) on clinical isolates of canine influenza virus (CIV).

VirusDrugEC50EC90SI

Ca/CO-1NTZ0.20  ±  0.010.70  ±  0.03331
TIZ0.20  ±  0.010.72  ±  0.03644

Ca/CO-3NTZ0.17  ±  0.010.60  ±  0.03391
TIZ0.17  ±  0.010.62  ±  0.03751

Ca/Co-4NTZ0.20  ±  0.010.71  ±  0.03329
TIZ0.19  ±  0.010.70  ±  0.03374

CIVNTZ0.21  ±  0.020.76  ±  0.03309
TIZ0.21  ±  0.020.75  ±  0.03619

EC50  or   90: Concentration (μM) of NTZ or TIZ at which a 2-fold (50%) or 10-fold (90%) reduction of viral titer is relative to untreated controls. EC50 and EC90 are expressed as means ± standard deviation.
SI: Selectivity Index (CC50/EC50).
Viral titers of three CIV isolates were analyzed using polynomial regression analysis. 95% confidence intervals for each value are displayed in parenthesis.